Yacov Geva - G Medical CEO and President
| GMVDWDelisted Stock | USD 4.01 0.00 0.00% |
Insider
Yacov Geva is CEO and President of G Medical Innovations
| Age | 73 |
| Phone | 972 8 958 4777 |
| Web | https://gmedinnovations.com |
G Medical Management Efficiency
The company has return on total asset (ROA) of (1.2631) % which means that it has lost $1.2631 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (8.6521) %, meaning that it generated substantial loss on money invested by shareholders. G Medical's management efficiency ratios could be used to measure how well G Medical manages its routine affairs as well as how well it operates its assets and liabilities.G Medical Innovations has accumulated 2.09 M in total debt. G Medical Innovations has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about G Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 5 records | INSIDER Age | ||
| Farrah Dean | BriaCell Therapeutics Corp | N/A | |
| FACP MD | BriaCell Therapeutics Corp | 78 | |
| Udi MD | Inspira Technologies Oxy | 41 | |
| Joe Hayon | Inspira Technologies Oxy | 50 | |
| Dagi BenNoon | Inspira Technologies Oxy | 48 | |
Management Performance
| Return On Equity | -8.65 | |||
| Return On Asset | -1.26 |
G Medical Innovations Leadership Team
Elected by the shareholders, the G Medical's board of directors comprises two types of representatives: G Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GMVDW. The board's role is to monitor G Medical's management team and ensure that shareholders' interests are well served. G Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, G Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oded Shahar, Sr Acquisition | ||
| Benny Tal, VP CTO | ||
| Kobi Efraim, Controller | ||
| Brett Tucker, Company Sec | ||
| Yacov Geva, CEO and President | ||
| Igor Bluvstein, Chief Officer | ||
| Dror NurielRoth, Ex Operations |
GMVDW Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is G Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -8.65 | |||
| Return On Asset | -1.26 | |||
| Operating Margin | (6.38) % | |||
| Revenue | 4.42 M | |||
| EBITDA | (37.75 M) | |||
| Net Income | (25.07 M) | |||
| Cash And Equivalents | 278 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 2.09 M | |||
| Current Ratio | 0.40 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in GMVDW Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |